Healthcare -
Biotechnology - NASDAQ - US
$ 7.54
-5.16 %
$ 63.5 M
Market Cap
-0.54
P/E
KPTI - INTEREST INCOME & EXPENSE
Interest Income & Expense KPTI - Karyopharm Therapeutics Inc.
37.4 M
LAST VALUE
22.36%
2 YEAR CAGR
19.05%
5 YEAR CAGR
186.62%
10 YEAR CAGR